Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hogy Medical Co's earnings before interest and taxes (EBIT) for the
three
months ended in Dec. 2025 was 円762 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was 円1,187 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Hogy Medical Co's annualizedROC % for the quarter that ended in Dec. 2025 was 3.28%.
Hogy Medical Co's annualizedROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.50%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Hogy Medical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.86%.
Hogy Medical Co (TSE:3593) EBIT Explanation
1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Hogy Medical Co's annualizedROC % for the quarter that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hogy Medical Co EBIT Related Terms
Hogy Medical Co EBIT Historical Data
* Premium members only.
The historical data trend for Hogy Medical Co's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Hogy Medical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hogy Medical Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hogy Medical Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Hogy Medical Co's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,187 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hogy Medical Co (TSE:3593) has a EBIT of 円1,187 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Hogy Medical Co.
Is Hogy Medical Co's EBIT too high?
Hogy Medical Co's current EBIT is 円1,187 Mil. Overall, Hogy Medical Co has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hogy Medical Co's EBIT compare to ISRG and BDX?
Hogy Medical Co's EBIT of 円1,187 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Hogy Medical Co. Hogy Medical Co's current EBIT is 円1,187 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hogy Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Hogy Medical Co (TSE:3593) is currently considered Significantly Overvalued. The stock's GF Value™ is 円4,422.15, compared to a current price of 円6,660.00 — trading 50.6% above its estimated fair value. The current EBIT is 円1,187 Mil. Hogy Medical Co's overall GF Score™ is 47/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Hogy Medical Co (TSE:3593), the current EBIT is 円1,187 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hogy Medical Co (TSE:3593) Overvalued in 2026?
Based on GuruFocus' analysis, Hogy Medical Co stock appears to be overvalued.
The current stock price of 円6,660.00 is trading 50.6% above its estimated GF Value™ of 円4,422.15.
GuruFocus considers Hogy Medical Co to be Significantly Overvalued.
Key valuation signals for TSE:3593:
EBIT: 円1,187 Mil
GF Value™: 円4,422.15 vs. price of 円6,660.00 (50.6% above fair value)
No single metric tells the full story. See the TSE:3593 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hogy Medical Co Ltd develops and sells products that can be used to streamline operations and improve safety at healthcare facilities. Its products are used in hospitals' operating rooms, wards, material rooms, and administrative settings. Hogy Medical receives the majority of its revenue from sales of surgical-use products. Its key products include kit products, nonwoven products, and sterilization products. The kit products contain sterilized surgical supplies for use in a specific operation. The nonwoven products include gowns, caps, equipment covers, and other accessories. Hogy's primary sterilization product is the Mekkin bag, a sterilization pouch. The vast majority of Hogy's revenue is generated in Japan.
47GF Score
Get the complete analysis for TSE:3593
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3593 has been successfully added to your 
